Potentialities of botulinum therapy in cosmetology
- Authors: Kapuler O.M.1
-
Affiliations:
- ZAO “Cosmetology Therapy”
- Issue: Vol 96, No 5 (2020)
- Pages: 19-23
- Section: REVIEWS
- URL: https://ogarev-online.ru/0042-4609/article/view/117528
- DOI: https://doi.org/10.25208/vdv1137-2020-96-5-19-23
- ID: 117528
Cite item
Full Text
Abstract
The desire to maintain youth as long as it possible in modern society, especially among women of working age, is primarily due to the desire to be in demand, well-groomed and attractive. Currently, there are 5 main methods that contribute to improving the condition of the skin of the face, namely: the method using professional cosmetics, chemical peels, mesotherapy, treatment with an injection of botulinum toxin type A (BTA) and intradermal implants based on hyaluronic acid.
The aim of the literature review was to analyze the latest scientific data on the possibility of botulinum therapy in cosmetology.
Wrinkles of open areas of the body (primarily on the face and in the decollete) have a negative effect on the emotional background and quality of life of women. In this regard, recently there has been a significant increase in demand for aesthetic medicine services, one of the areas of which is botulinum therapy (BT). Botulinum toxin type A (BTA) is a powerful neurotoxin that inhibits the release of acetylcholine in the neuromuscular junction. Injections of small doses of botulinum toxin type A into targeted mimic muscles cause their relaxation, which smoothes the underlying layer of the skin, thereby regressing mimic wrinkles. Today, according to officially approved indications, it is used in cosmetology, botulinum therapy is used to correct mimic wrinkles in the upper third of the face, drooping corners of the mouth, in the complex correction of the face oval, in the treatment of axillary and palmar hyperhidrosis. Blocking a tear mediator like acetylcholine, not only the presynaptic membranes of neuromuscular synapses are rich, but also many anatomical structures, such as glandular tissue (sweat, other glands, etc.). This commonality of the mechanism of action on various physiological processes in our body allows us to make an assumption about the great potential of botulinum therapy in the treatment of a number of diseases associated with impaired neuromuscular conduction.
Full Text
##article.viewOnOriginalSite##About the authors
O. M. Kapuler
ZAO “Cosmetology Therapy”
Author for correspondence.
Email: olga.kapuler@bk.ru
Doctor of Medical Sciences, Deputy Chief Physician for Medical Work, ZAO “Cosmetology Therapy
Russian Federation, Komsomolskауа str., 37, Ufa, 450009, RussiaReferences
- Solish N, Rivers J, Humphrey S, et al. Efficacy and Safety of Onabotulinumtoxin A Treatment of Forehead Lines. Dermatologic Surgery 2016;42(3):410–419. doi: 10.1097/dss.0000000000000626
- Dastoor S, Misch C, Wang H. Botulinum Toxin (Botox) to Enhance Facial Macroesthetics: A Literature Review. Journal of Oral Implantology 2007;33(3):164–171. doi: 10.1563/0-835.1
- Ziade M, Domergue S, Batifol D, et al. Use of botulinum toxin type A to improve treatment of facial wounds: A prospective randomised study. Journal of Plastic, Reconstructive & Aesthetic Surgery 2013;66(2):209–214. doi: 10.1016/j.bjps.2012.09.012
- Zhou R, Pan B, Wang C, Wang D. Mandibular Rim Trilogy with Botulinum Toxin Injection: Reduction, Projection, and Lift. Facial Plastic Surgery 2017;33(01):102–108. doi: 10.1055/s-0037-1600525
- Steinsapir K, Rootman D, Wulc A, Hwang C. Cosmetic Microdroplet Botulinum Toxin A Forehead Lift. Ophthalmic Plast Reconstr Surg 2015;31(4):263–268. doi: 10.1097/iop.0000000000000282
- Vikelis M, Argyriou A, Dermitzakis E, Spingos K, Makris N, Kararizou E. Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment. J Headache Pain 2018;19(1). doi: 10.1186/s10194-018-0918-3
- Saromitskaya AN, Atamanov VV. Optimization of type A botulinum neurotoxin injection considering aesthetic indications: multifocal method. Bulletin of aesthetic medicine 2013;1:20–27.
- Разумовская Е.А. Личный опыт проведения ботулинотерапии в комбинации с блефаропластикой. Инъекционные методы в косметологии. 2011;4:36–42. [Razumovskaya EA. Personal experience with botulinum therapy in combination with blepharoplasty. Injection methods in cosmetology 2011;4:36–42 (In Russ.)]
- Won C, Lee H, Lee W, et al. Efficacy and Safety of a Novel Botulinum Toxin Type A Product for the Treatment of Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled Multicenter Study. Dermatologic Surgery. 2013;39(1pt2):171–178. doi: 10.1111/dsu.12072
- De Maio M, Rzany B. Botulinum Toxin in Aesthetic Medicine. Springer-Verlag Berlin AN; 2007.
- Yiannakopoulou E. Serious and Long-Term Adverse Events Associated with the Therapeutic and Cosmetic Use of Botulinum Toxin. Pharmacology. 2015;95(1–2):65–69. doi: 10.1159/000370245
- Carruthers A, Carruthers J. A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: Safety and efficacy. J Am Acad Dermatol. 2009;60(6):972–979. doi: 10.1016/j.jaad.2009.01.005
- Ascher B, Talarico S, Cassuto D, et al. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) — part I: upper facial wrinkles. Journal of the European Academy of Dermatology and Venereology. 2010;24(11):1278–1284. doi: 10.1111/j.1468-3083.2010.03631.x
- Tao Y, Bin Jameel A, Miao Y, et al. The self-recovery of facial skin barrier and erythema after nanochip treatment. Journal of Cosmetic and Laser Therapy. 2017;19(7):427–433. doi: 10.1080/14764172.2017.1341984
- Heckmann M, Ceballos-Baumann A, Plewig G. Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating). New England Journal of Medicine. 2001;344(7):488–493. doi: 10.1056/nejm200102153440704
- Philipp-Dormston WG. Botulinum toxin in dermatology. Hautarzt. 2014;65(2):133–143. doi: 10.1007/s00105-013-2744-5
Supplementary files
